SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Johannes M. Waldschmidt, Anna Simon, Dagmar Wider, Stefan J. Müller, Marie Follo, Gabriele Ihorst, Sarah Decker, Joschka Lorenz, Manik Chatterjee, Abdel K. Azab, Justus Duyster, Ralph Wäsch, Monika Engelhardt, CXCL12 and CXCR7 are relevant targets to reverse cell adhesion-mediated drug resistance in multiple myeloma, British Journal of Haematology, 2017, 179, 1
  2. 2
    Haixia Ding, Lianmei Zhao, Suli Dai, Lei Li, Fujun Wang, Baoen Shan, CCL5 secreted by tumor associated macrophages may be a new target in treatment of gastric cancer, Biomedicine & Pharmacotherapy, 2016, 77, 142

    CrossRef

  3. 3
    Joschka Lorenz, Johannes Waldschmidt, Dagmar Wider, Marie Follo, Gabriele Ihorst, Manik Chatterjee, Annette M. May, Justus Duyster, Andreas Rosenwald, Ralph Wäsch, Katja Zirlik, Monika Engelhardt, From CLL to Multiple Myeloma - Spleen Tyrosine Kinase (SYK) influences multiple myeloma cell survival and migration, British Journal of Haematology, 2016, 174, 6
  4. 4
    Massimo Gentile, Massimo Martino, Anna Grazia Recchia, Ernesto Vigna, Lucio Morabito, Fortunato Morabito, Sorafenib for the treatment of multiple myeloma, Expert Opinion on Investigational Drugs, 2016, 25, 6, 743

    CrossRef

  5. 5
    Juliette M.C. Bouyssou, Irene M. Ghobrial, Aldo M. Roccaro, Targeting SDF-1 in multiple myeloma tumor microenvironment, Cancer Letters, 2016, 380, 1, 315

    CrossRef

  6. 6
    J. Paton-Hough, A.D. Chantry, M.A. Lawson, A review of current murine models of multiple myeloma used to assess the efficacy of therapeutic agents on tumour growth and bone disease, Bone, 2015, 77, 57

    CrossRef

  7. 7
    Gabriele Ihorst, Johannes Waldschmidt, Martin Schumacher, Ralph Wäsch, Monika Engelhardt, Analysis of survival by tumor response: have we learnt any better?, Annals of Hematology, 2015, 94, 9, 1615

    CrossRef

  8. 8
    Michelle A. Lawson, Julia M. Paton-Hough, Holly R. Evans, Rebecca E. Walker, William Harris, Dharshi Ratnabalan, John A. Snowden, Andrew D. Chantry, Ranji Cui, NOD/SCID-GAMMA Mice Are an Ideal Strain to Assess the Efficacy of Therapeutic Agents Used in the Treatment of Myeloma Bone Disease, PLOS ONE, 2015, 10, 3, e0119546

    CrossRef

  9. 9
    Nathan G. Dolloff, 2015,

    CrossRef

  10. 10
    Ingunn Holen, Michelle A. Lawson, Bone Cancer, 2015,

    CrossRef

  11. 11
    M. Engelhardt, F. Gaiser, J. Waldschmidt, R. Wäsch, M. Kleber, Basisdiagnose, klinisches Spektrum von Plasmazellerkrankungen und Risikostratifizierung, Der Onkologe, 2014, 20, 3, 217

    CrossRef

  12. 12
    Donatella Aldinucci, Alfonso Colombatti, The Inflammatory Chemokine CCL5 and Cancer Progression, Mediators of Inflammation, 2014, 2014, 1

    CrossRef

  13. 13
    Fabrizio Vinante, Antonella Rigo, Heparin-Binding Epidermal Growth Factor-like Growth Factor/Diphtheria Toxin Receptor in Normal and Neoplastic Hematopoiesis, Toxins, 2013, 5, 12, 1180

    CrossRef

  14. 14
    Julia Schueler, Dagmar Wider, Kerstin Klingner, Gabrielle M. Siegers, Annette M. May, Ralph Wäsch, Heinz-Herbert Fiebig, Monika Engelhardt, Zoran Ivanovic, Intratibial Injection of Human Multiple Myeloma Cells in NOD/SCID IL-2Rγ(Null) Mice Mimics Human Myeloma and Serves as a Valuable Tool for the Development of Anticancer Strategies, PLoS ONE, 2013, 8, 11, e79939

    CrossRef

  15. 15
    Julia Schüler, Daniel Ewerth, Johannes Waldschmidt, Ralph Wäsch, Monika Engelhardt, Preclinical models of multiple myeloma: a critical appraisal, Expert Opinion on Biological Therapy, 2013, 13, sup1, S111

    CrossRef

  16. 16
    Katharina Lückerath, Constantin Lapa, Annika Spahmann, Gerhard Jörg, Samuel Samnick, Andreas Rosenwald, Herrmann Einsele, Stefan Knop, Andreas K. Buck, Evren Alici, Targeting Paraprotein Biosynthesis for Non-Invasive Characterization of Myeloma Biology, PLoS ONE, 2013, 8, 12, e84840

    CrossRef